Seth Rudnick

This profile gathers the share dealings of Seth Rudnick across 2 companies, led by G1 Therapeutics, Inc. and Aralez Pharmaceuticals Inc. Between 5 February 2016 and 29 June 2021, the trades on record add up to 3 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The latest filing, published on 30 June 2021, reports an option exercise of €2,611 in G1 Therapeutics, Inc. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.